Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Fluzoparib Plus Famitinib Maintenance After First-Line Platinum Response in Advanced Ovarian Cancer [Phase 2]
This entry describes a Phase 2 clinical trial evaluating maintenance therapy with a combination of fluzoparib and famitinib after a first-li…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE) [NA]
A prospective biobanking study by Institut Curie (SCANDARE) aims to understand how tumor molecular alterations relate to the tumor microenvi…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2
A prospective cohort trial is recruiting germline BRCA1/BRCA2 variant carriers to study cancer risk in ovarian, fallopian tube, and primary …
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions [NA]
A Mayo Clinic-sponsored clinical trial is evaluating ultrasound microvessel imaging to help characterize ovarian and adnexal lesions, and is…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors [Phase 1]
Phase 1 clinical trial update indicates a study of Olaparib in combination with ASTX727 for BRCA1/2- and homologous recombination deficiency…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE) [NA]
Completed clinical trial PREPARE evaluated a geriatric intervention in the treatment of older cancer patients. The update does not include t…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of CYH33 in patients with recurrent/persistent ovarian clear cell carcinoma.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Impact of Specific Monitoring of Intraoperative Analgesia Under General Anesthesia on Chronic Pain After Ovarian Cancer Surgery [NA]
Clinical trial update on the impact of targeted intraoperative analgesia monitoring under general anesthesia on chronic pain after ovarian c…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating BL-B01D1 in patients with metastatic or unresectable non-small cell lung cancer and other solid tumors is …
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised Management [NA]
This ClinicalTrials.gov update describes a study evaluating pretreatment sarcopenia in patients with inoperable high-grade ovarian carcinoma…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study [NA]
This is a pilot study evaluating an e-health Day-by-Day intervention to help manage Fear of Progression in women with stage III or IV gyneco…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: A Study of IMP4297 as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer [Phase 3]
A Phase 3 clinical trial assessing IMP4297 as maintenance therapy after first-line chemotherapy in patients with advanced ovarian cancer; th…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Registry Platform Ovarian and Endometrial Cancer
This is a ClinicalTrials.gov registry entry for a recruiting study sponsored by iOMEDICO AG, investigating ovarian cancer and endometrial ca…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Trauma-Focused Managing Cancer And Living Meaningfully (CALM-TF) for Newly Diagnosed and Recurrent Ovarian Cancer [Phase 3]
This Phase 3 clinical trial update outlines CALM-TF, a trauma-focused psychotherapy program, being studied for newly diagnosed and recurrent…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: To Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as Maintenance Therapy in Relapsed Ovarian Cancer [Phase 2]
A Phase 2 clinical trial is planned to evaluate the efficacy and safety of JPI-547 in combination with bevacizumab as maintenance therapy fo…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Biomarkers of Resiliency In Childhood Cancer Surgery
Clinical trial update from Mayo Clinic on biomarkers of resiliency in pediatric cancer surgery, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life [NA]
A trial is exploring whether a hand and foot exercise program can reduce chemotherapy-induced peripheral neuropathy and improve quality of l…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer [NA]
A clinical trial is evaluating opportunistic salpingectomy as a preventive measure to reduce ovarian cancer risk, and it is currently recrui…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer [Phase 1]
A Phase 1b trial is evaluating lurbinectedin in combination with weekly paclitaxel and bevacizumab for platinum-resistant ovarian cancer; th…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Randomized, Open-label, Double-cohort Study of Fluzoparib Combined With Famitinib Malate or SHR-1701 for Neoadjuvant Therapy in Patients With Advanced Ovarian Cancer [Phase 2]
Phase 2 randomized neoadjuvant trial evaluating Fluzoparib in combination with Famitinib Malate or SHR-1701 for advanced ovarian cancer; the…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: EXoPERT EMERALD Clinical Study
Clinical trial update indicates the EXoPERT EMERALD study is currently recruiting across multiple cancer indications, including breast, colo…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer [Phase 1]
Phase 1 study to assess adverse events, changes in disease activity, and pharmacokinetics of intravenous ABBV901 given alone or with Bevaciz…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer [Phase 3]
Phase 3 trial recruitment is ongoing for AZD5335 versus Mirvetuximab Soravtansine in FRα-high epithelial ovarian cancer and AZD5335 versus c…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating Juice Plus+ and Juice Plus+ Complete in ovarian cancer is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Lead-212 PSV359 Therapy for Patients With Solid Tumors [Phase 1, Phase 2]
Perspective Therapeutics reports that Lead-212 PSV359 Therapy is being studied in Phase 1/2 trials for multiple solid tumors and is currentl…